US Asks Cephalon For Data On [Off-Label] Promotion Of Drug Treanda [Benfamustin]

[Guest guest]

Blank

US Asks Cephalon For Data On [off-label Promotion Of Drug Treanda [bendamustin]

DOW JONES NEWSWIRES

The U.S. Justice Department has asked Cephalon Inc. (CEPH) about documents

relating to alleged off-label promotion of its Treanda treatment for chronic

lymphocytic leukemia, the pharmaceutical industry news site Pharmalot.com

reported Monday.

The June request to the Pennsylvania-based drug maker concerned first-line

treatment of non-Hodgkin's lymphoma, for which Treanda isn't approved, according

to sources familiar with the request. Also requested were clinical studies that

could be used to support off-label use before the studies were completed or

submitted for review by the U.S. Food and Drug Administration.

A Cephalon spokeswoman declined to comment, Pharmalot.com reported.

Full story at

http://www.pharmalot.com/2011/07/feds-probe-cephalon-for-off-label-treanda-promo\

tion/